To partially compensate for this deficiency, we leveraged The Cancer Genome Atlas (TCGA) database and studied the mRNA levels of METTL3 and TFAP2C in seminoma and non‐seminoma samples (Figure 1B,C). The gene discussed is METTL3; the disease is seminoma.